Different plasma levels of interleukins and chemokines: Comparison between children and adults with AIDS in China

Chinese Medical Journal

Volumn 122, Issue 5, 2009, Pages 530-535

  Jin, Chang Zhong ^a   Zhao, Yan ^b   Zhang, Fu Jie ^b   Yao, Hang Ping ^a   Wu, Ling Jiao ^a   Zhao, Hong Xin ^c   Wei, Hong Shan ^c   Wu, Nan Ping ^a  

^a ZHEJIANG UNIVERSITY   (China)

^b CHINESE CENTER FOR DISEASE CONTROL AND PREVENTION   (China)

^c CAPITAL MEDICAL UNIVERSITY   (China)

Author keywords

Acquired immunodeficiency syndrome; Chemokine; Child; Immune status; Interleukin

Indexed keywords

BETA 2 MICROGLOBULIN; CD4 ANTIGEN; CHEMOKINE; CYTOKINE; FAS ANTIGEN; INTERLEUKIN 10; INTERLEUKIN 16; INTERLEUKIN 18; MONOCYTE CHEMOTACTIC PROTEIN 1; RANTES; STROMAL CELL DERIVED FACTOR 1ALPHA; STROMAL CELL DERIVED FACTOR 1BETA; VIRUS RNA; INTERLEUKIN DERIVATIVE; STROMAL CELL DERIVED FACTOR 1;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; AGE; ARTICLE; CD4+ T LYMPHOCYTE; CELLULAR IMMUNITY; CHILD; CHINA; CONTROLLED STUDY; DISEASE COURSE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; HUMORAL IMMUNITY; IMMUNOSTIMULATION; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; PRESCHOOL CHILD; SCHOOL CHILD; TH1 CELL; TH2 CELL; VIRUS LOAD; AGE DISTRIBUTION; AGED; BLOOD; GENETICS; MIDDLE AGED; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; VIROLOGY;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ADULT; AGE DISTRIBUTION; AGED; CHEMOKINE CCL2; CHEMOKINE CCL5; CHEMOKINE CXCL12; CHEMOKINES; CHILD; CHILD, PRESCHOOL; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; HIV-1; HUMANS; INTERLEUKIN-10; INTERLEUKIN-16; INTERLEUKIN-18; INTERLEUKINS; MALE; MIDDLE AGED; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, VIRAL; VIRAL LOAD;

EID: 65649115771     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: 10.3760/cma.j.issn.0366-6999.2009.05.009     Document Type: Article

References (30)

1. Garzino-Demo A, DeVico AL, Conant KE, Gallo RC. The role of chemokines in human immunodeficiency virus infection. Immunol Rev 2000; 177: 79-87.
2. Howie S, Ramage R, Hewson T. Innate immune system damage in human immunodeficiency virus type 1 infection. Implications for acquired immunity and vaccine design. Am J Respir Crit Care Med 2000; 162 (4 Pt 2): 141-145.
3. Alfano M, Poli G. Cytokine and chemokine based control of HIV infection and replication. Curr Pharm Des 2001; 7: 993-1013.
4. Gerard C, Rollins BJ. Chemokines and disease. Nat Immunol 2001; 2: 108-115.
5. Klein S, Dobmeyer J, Dobmeyer TS, Pape A, Ottmann OG, Helm EB, et al. Demonstration of the Th1 to Th2 cytokine shift during the course of HIV-1 infection using cytoplasmic cytokine detection on single cell level by flow cytometry. AIDS 1997; 11: 1111-1118.
6. Yoshioka M, Bradley WG, Shapshak P, Nagano I, Stewart RV, Xin KQ, et al. Role of immune activation and cytokine expression in HIV-1 associated neurological disease. Adv Neuroimmunol 1995; 5: 335-358.
7. + cell responses against human immunodeficiency virus: implications for long-term survival. Proc Natl Acad Sci U S A 1995; 92: 11135-11139.
8. Bogner JR, Walli R, Goebel FD. Th1/Th2 shift in HIV lymph nodes: no contribution of CD60 cells. Infection 2001; 29: 32-36.
9. Hyjek E, Lischner HW, Hyslop T, Bartkowiak J, Kubin M, Trinchieri G, et al. Cytokine patterns during progression to AIDS in children with perinatal HIV infection. J Immunol 1995; 155: 4060-4071.
10. Klein SA, Dobmeyer JM, Dobmeyer TS, Pape M, Ottmann OG, Helm EB, et al. Demonstration of the Th1 to Th2 cytokine shift during the course of HIV-1 infection using cytoplasmic cytokine detection on single cell level by flow cytometry. AIDS 1997; 11: 1111-1118.
11. Zhou P, Goldstein S, Devadas K, Tewari D, Notkins AL. Human CD41 cells transfected with IL-16 cDNA are resistant to HIV-1 infection: inhibition of mRNA expression. Nat Med 1997; 3: 659-664.
12. Choi HJ, Dinarello CA, Shapiro L. Interleukin-18 inhibits human immunodeficiency virus type 1 production in peripheral blood mononuclear cells. J Infect Dis 2001; 184: 560.
13. Ministry of Health, People's Republic of China. 2005 update on the HIV/ AIDS epidemic and response in China. Beijing: Ministry of Health, People's Republic of China, joint United Nations Programme on HIV/AIDS and World Health Organization. 2006: 4-9.
14. Bakaki P, Kayita J, Moura Machado JE, Coulter JB, Tindyebwa D, Ndugwa CM et al. Epidemiologic and clinic features of HIV-infected and HIV-uninfected Ugandan children younger than 18 months. J Acquir Immune Defic Syndr 2001; 28: 35-42.
15. Berhane R, Bagenda D, Marum L, Aceng E, Ndugwa C, Bosch RJ, et al. Growth failure as a prognostic indicator of mortality in pediatric HIV infection. Pediatrics 1997; 100: E7.
16. John G. Barlett. The Johns Hopkins hospital 2003 guide to medical care of patients with HIV infection. 11th ed Philadelphia: Lippincott Williams & Wilkins; 2003: 9.
17. Suresh P, Wanchu A. Chemokines and chemokine receptors in HIV infection: role in pathogenesis and therapeutics. J Postgrad Med 2006; 52: 210-217.
18. CDC. 1993 Revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. MMWR 1992; 41 (No. RR-17): 1-17.
19. CDC. 1994 Revised classification system for human immunodeficiency virus infection in children less than 13 years of age. MMWR 1994; 43 (No. RR-12): 1-10.
20. van Rossum AM, Scherpbier HJ, van Lochem EG, Pakker NG, Slieker WA, Wolthers KC, et al. Therapeutic immune reconstitution in HIV-1-infected children is independent of their age and pretreatment immune status. AIDS 2001; 15: 2267-2275.
21. Zhang ZN, Shang H, Jiang YJ, Liu J, Dai D, Diao YY, et al. Activation and coreceptor expression of T lymphocytes induced by highly active antiretroviral therapy in Chinese HIV/AIDS patients. Chin Med J 2006; 119: 1966-1971.
22. + lymphocyte parameters in HIV at risk uninfected children. Clin Infect Dis 1993; 17: 123-126.
23. Marshall-Clarke S, Reen D, Tasker L, Hassan J. Neonatal immunity: how well has it grown up? Immunol Today 2000; 21: 35-41.
24. Connor E, Bagarazzi M, McSherry G, Holland B, Boland M, Denny T, et al. Clinical and laboratory correlates of Pneumocystis carinii pneumonia in children infected with HIV. JAMA 1991; 265: 1693-1697.
25. + T lymphocyte regeneration after intensive chemotherapy. N Engl J Med 1995; 332: 143-149.
26. Adkins B. T-cell function in newborn mice and humans. Immunol Today 1999; 20: 330-335.
27. Jones BM, Chiu SS, Wong WH, Lim WW, Lau YL. Cytokine profiles in human immunodeficiency virus-infected children treated with highly active antiretroviral therapy. Med Gen Med 2005; 3: 71.
28. Appay V, Papagno L, Spina CA, Hansasuta P, King A, Jones L, et al. Dynamics of T cell responses in HIV infection. J Immunol 2002; 168: 3660-3666.
29. Smiatacz T. Immune mechanisms in HIV infection and their role in antiretroviral therapy. Przegl Epidemiol 2003; 57: 30-316.
30. Naora H, Gougeon ML. Enhanced survival and potent expansion of the natural killer cell population of HIV-infected individuals by exogenous interleukin-15. Immunol Lett 1999; 68: 359-367